Lv32
240 积分 2024-03-13 加入
Urinary tract infection following the use of BTK inhibitors: a real-world analysis of post-marketing surveillance data
12天前
已完结
Pharmacovigilance analysis of cardiac risks associated with Bruton tyrosine kinase inhibitors
12天前
已完结
Investigating bleeding adverse events associated with BTK inhibitors in the food and drug administration adverse event reporting system (FAERS)
12天前
已完结
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for Bruton's tyrosine kinase inhibitors (BTKis) single and its combination therapy
12天前
已完结
Cardiovascular events of Bruton's tyrosine kinase inhibitors: A real-world study based on the United States Food and Drug Administration Adverse Event Reporting System database
12天前
已完结
Real World Experience of the BTK Inhibitors. Comparing Cardiac, Vascular and Infectious Toxicities
15天前
已完结
Real World Experience of the BTK Inhibitors. Comparing Cardiac, Vascular and Infectious Toxicities
15天前
已关闭
Measuring haemoglobin concentration to define anaemia: WHO guidelines
24天前
已完结
Assessment of the impact of partial area under the curve in a bioavailability/bioequivalence study on generic prolonged-release formulations
1个月前
已完结
皖公网安备34019202002308
